PURPOSE OF REVIEW: Insulin resistance plays a significant role in both morbidity and mortality of the general population. Understanding the molecular mechanisms of insulin resistance would help the identification of at-risk individuals in the presymptomatic stage, and the discovery of novel and more effective treatments. The transmembrane glycoprotein ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) inhibits insulin receptor signalling and has recently emerged as a key player in the development of insulin resistance. This review will summarize data available on the relationship between ENPP1 and insulin resistance. RECENT FINDINGS: Overexpression of ENPP1 in insulin target tissues is an early, intrinsic defect observed in human insulin resistance. A missense ENPP1 single nucleotide polymorphism, K121Q, has been recently described with the Q121 variant being a stronger inhibitor than K121 of insulin receptor function. In addition, the Q121 variant has been repeatedly associated with insulin resistance and related abnormalities including body weight changes, type 2 diabetes and macrovascular complications, thus suggesting a pleiotropic role of the ENPP1 gene on several metabolic abnormalities. SUMMARY: A deep understanding of ENPP1 mode of action and the mechanisms regulating its expression and function are likely to provide new tools for early identification and treatments of patients at risk for the devastating clinical outcomes related to insulin resistance.
PURPOSE OF REVIEW: Insulin resistance plays a significant role in both morbidity and mortality of the general population. Understanding the molecular mechanisms of insulin resistance would help the identification of at-risk individuals in the presymptomatic stage, and the discovery of novel and more effective treatments. The transmembrane glycoprotein ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) inhibits insulin receptor signalling and has recently emerged as a key player in the development of insulin resistance. This review will summarize data available on the relationship between ENPP1 and insulin resistance. RECENT FINDINGS: Overexpression of ENPP1 in insulin target tissues is an early, intrinsic defect observed in humaninsulin resistance. A missense ENPP1 single nucleotide polymorphism, K121Q, has been recently described with the Q121 variant being a stronger inhibitor than K121 of insulin receptor function. In addition, the Q121 variant has been repeatedly associated with insulin resistance and related abnormalities including body weight changes, type 2 diabetes and macrovascular complications, thus suggesting a pleiotropic role of the ENPP1 gene on several metabolic abnormalities. SUMMARY: A deep understanding of ENPP1 mode of action and the mechanisms regulating its expression and function are likely to provide new tools for early identification and treatments of patients at risk for the devastating clinical outcomes related to insulin resistance.
Authors: P Coletta; G Barbarossa; D Pergolini; L D'Erasmo; A Renzi; L Mercuri; M G Anatra; E Ciociola; A Verrienti; M Maranghi Journal: Endocrine Date: 2012-08-17 Impact factor: 3.633
Authors: Sadia Abbasi; Dong-Mi Shin; Natalie Beaty; Marek Masiuk; Sophia Chen; Ines Gonzalez-Garcia; Ming Zhao; James Goding; Herbert C Morse; Hongsheng Wang Journal: Hybridoma (Larchmt) Date: 2011-02
Authors: Arzu Umar; Hyuk Kang; Annemieke M Timmermans; Maxime P Look; Marion E Meijer-van Gelder; Michael A den Bakker; Navdeep Jaitly; John W M Martens; Theo M Luider; John A Foekens; Ljiljana Pasa-Tolić Journal: Mol Cell Proteomics Date: 2009-03-27 Impact factor: 5.911